⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30876775 | 0.89 | TRIM24 (0.45) | — | |
| SCHEMBL14791364 | 0.81 | — | — | |
| SCHEMBL16697083 | 0.76 | — | — | |
| SCHEMBL15181868 | 0.75 | — | — | |
| SCHEMBL22690012 | 0.75 | TRIM24 (0.36) | — | |
| SCHEMBL15537876 | 0.73 | MEN1 (0.34) | — | |
| SCHEMBL9171769 | 0.72 | TRIM24 (0.44) | — | |
| SCHEMBL9902103 | 0.69 | MEN1 (0.32) | — | |
| SCHEMBL307414 | 0.69 | — | — | |
| SCHEMBL16099106 | 0.69 | TRIM24 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1414 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3249682-B1 | SUBSTRATE TREATING METHOD | SCREEN HOLDINGS CO LTD (JP) | 2022-08-24 | — | — | EP | claimed |
| CN-113929598-A | Synthesis method of (S) -2-tert-butyloxycarbonylamino-3- (4, 4-difluorocyclohexyl) propionic acid | 上海吉奉生物科技有限公司 | 2022-01-14 | — | — | CN | claimed |
| CN-107481954-B | Substrate processing apparatus and substrate processing method | 株式会社斯库林集团 | 2020-11-20 | — | — | CN | claimed |
| US-10153181-B2 | Substrate treating apparatus and substrate treating method | SCREEN Holdings Co., Ltd. (JP) | 2018-12-11 | — | — | US | claimed |
| US-20170345683-A1 | SUBSTRATE TREATING APPARATUS AND SUBSTRATE TREATING METHOD | SCREEN Holdings Co., Ltd. (JP) | 2017-11-30 | — | — | US | claimed |
| EP-3249682-A1 | SUBSTRATE TREATING APPARATUS AND SUBSTRATE TREATING METHOD | SCREEN Holdings Co., Ltd. (JP) | 2017-11-29 | — | — | EP | claimed |
| CN-103086849-B | Liquid crystal compound and composition thereof | BEIJING BAYI SPACE LCD MATERIALS TECHNOLOGY CO LTD | 2015-05-27 | — | — | CN | claimed |
| CN-103086849-A | Liquid crystal compound and composition thereof | BEIJING BAYI SPACE LCD MATERIALS TECHNOLOGY CO LTD | 2013-05-08 | — | — | CN | claimed |
| CN-102550567-A | Method for preparing novel weedicide | SHANGHAI SINOFLUORO SCIENT CO | 2012-07-11 | — | — | CN | claimed |
| CN-102524262-A | Composition containing 4,4-difluoro-cyclohexanone and application | SHANGHAI SINOFLUORO SCIENT CO | 2012-07-04 | — | — | CN | claimed |
| EP-4748837-A1 | AROMATIC AMIDE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Zhejiang Hisun Pharmaceutical Co., Ltd. (CN) | 2026-05-27 | — | — | EP | disclosed |
| US-12637467-B2 | Inhibitor of BTK and mutants thereof | NEWAVE PHARMACEUTICAL INC. (US) | 2026-05-26 | — | — | US | disclosed |
| EP-4743453-A1 | MODULATORS OF MITOCHONDRIAL DNA REPLICATION | Pretzel Therapeutics, Inc. (US) | 2026-05-20 | — | — | EP | disclosed |
| US-20260132109-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | NOVARTIS PHARMA AG (CH) | 2026-05-14 | — | — | US | disclosed |
| US-20260116869-A1 | AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS | NOVARTIS AG (CH) | 2026-04-30 | — | — | US | disclosed |
| US-20040229893-A1 | Substituted benzothiazole amide derivatives | FLOHR ALEXANDER (CH) | 2004-11-18 | — | — | US | disclosed |
| EP-1455792-A1 | UREAS OF 2-AMINOBENZOTHIAZOLES AS ADENOSINE MODULATORS | F. HOFFMANN-LA ROCHE AG (CH) | 2004-09-15 | — | — | EP | disclosed |
| US-6727247-B2 | ADENOSINE RECEPTOR LIGANDS IN A METHOD OF TREATMENT, CONTROL, OR PREVENTION OF CENTRAL NERVOUS SYSTEM DISORDERS | HOFFMAN-LA ROCHE INC. | 2004-04-27 | — | — | US | disclosed |
| US-20030149036-A1 | Substituted benzothiazole amide derivatives | HOFFMAN-LA ROCHE INC. | 2003-08-07 | — | — | US | disclosed |
| WO-2003049741-A1 | UREAS OF 2-AMINOBENZOTHIAZOLES AS ADENOSINE MODULATORS | F. HOFFMANN-LA ROCHE AG (CH) | 2003-06-19 | — | — | WO | disclosed |